How can you not read a post with that title? Unfortunately, we can't take credit for it. The blogger over at Gawker published a post that we found pretty interesting about a type of advertising that uses your skull as a speaker. Definitely a lot more creative than using tattoos...
Schizophrenia is a devastating brain disorder that torments sufferers with hallucinations, delusions, disordered thinking patterns, and memory deficits. It is especially tragic because it usually strikes during the late teens, 20s, or early 30s, right when individuals are establishing families and careers of their own. It costs society $32.5 billion...
Schizophrenia has been conceptualized as a failure of cognitive integration, and abnormalities in neural circuitry have been proposed as a basis for this disorder. They used measures of phase locking and phase coherence in the scalp-recorded electroencephalogram to examine the synchronization of neural circuits in schizophrenia. Compared with matched control...
Schizophrenia is a severe mental disorder that affects nearly 1% of the general population and has long been a challenge for both clinicians and researchers in terms of treatment and etiology. More recently, evidence has amassed that suggests that schizophrenia is a brain disorder, and that some aspects of this...
The fusiform gyrus occipitotemporal gyrus is thought to be critical for face recognition and may possibly be associated with impaired facial recognition and interpretation of facial expression in schizophrenia. Results of postmortem studies have suggested that fusiform gyrus volume is reduced in schizophrenia, but there have been no in vivo...
Building on Foundation in Schizophrenia, Personalized Medicine Testing Strategy Will Expand to Include Depression, Alzheimer's and Other CNS Disorders CAMBRIDGE, Mass. & LONDON -- TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment...
Other Atypicals Thrive by Capturing Specific Patient Populations, According to a New Report from Decision Resources WALTHAM, Mass., July 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Janssen's Risperdal continues to be the...
By James Carlson THE CAPITAL-JOURNAL Bob Owen was as normal a teenager as any other. He played baseball and basketball, quarterbacked the football team and led the hockey team at his high school in a Minneapolis suburb in the early 1950s....
By James Carlson THE CAPITAL-JOURNAL Bob Owen was as normal a teenager as any other. He played baseball and basketball, quarterbacked the football team and led the hockey team at his high school in a Minneapolis suburb in the early 1950s....
PROVO -- Attorneys for a man charged with aggravated murder who is accused of stabbing his father repeatedly with a kitchen knife asked for a competency evaluation Thursday. The motion was granted. Authorities say Michael Kirsch, 31, got into an argument with his father June 15 in...
AstraZeneca wins Seroquel case *The Anglo-Swedish pharmaceutical group AstraZeneca received a boost yesterday when an American court upheld its patent over the $4bn- (2bn) a- year schizophrenia and bipolar blockbuster Seroquel. The New Jersey District Court awarded AstraZeneca summary judgment in the face of...
Taking prescription medications can help reduce violent behavior in some schizophrenia patients, Duke researchers report. It included 1,445 schizophrenia patients randomly selected to receive one of five antipsychotic medications: olanzapine, perphenanize, quetiapine, risperidone or ziprasidone. Patient violence declined significantly when patients took their medications as prescribed, but only among patients...
Sun Y, Vestergaard M, Christensen J, Nahmias AJ, Olsen J. Prenatal exposure to maternal infections and epilepsy in childhood: a population-based cohort study. Pediatrics, 2008; doi:10.1542/peds.2007-2316 (1 May 2008). Prenatal exposure to some maternal infections is associated with an increased risk for epilepsy in early childhood, a Danish...
TITUSVILLE, N.J., June 30 /PRNewswire-FirstCall/ -- Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced that it has launched an authorized generic version of RISPERDALR risperidone through Patriot Pharmaceuticals, L.L.C. Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of...
PROVO -- Kelly Wark, the woman killed by police after she shot a Lehi captain twice in the head, often told her ex-husband that she would rather be dead than live in constant fear. "She was in her own personal hell," said Craig Hancock, who was married...
Adding small co-payments to Medicaid prescription drug plans reduces the use of medications by patients with chronic diseases, says a U.S. study. $2 for generic and $3 for brand-name -- for prescription drugs introduced for Oregon Medicaid enrollees in 2003. The co-pay fees weren't required for patients who were unable...
- Results in Proceeds of $2 Million - MONTVALE, N.J., June 24 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that it has secured $2 million through the sale of approximately 4.7 million shares of common stock under its equity financing agreement with an investment group led...
Efficacy and safety data were generally consistent with oral olanzapine with the exception of injection-related events VENICE, Italy, June 23 /PRNewswire-FirstCall/ -- Results from olanzapine long-acting injection LAI clinical trials showed that the efficacy and safety profile of olanzapine LAI was generally consistent with that of ZyprexaR...
MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. announced today that it will present results of its Phase 2a clinical trial of StaccatoR loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting of the American Headache Society, which being held at...
The prescribing of powerful anti-psychotic drugs to patients with dementia is to be reviewed immediately, ministers have said. The announcement follows evidence that up to half of GPs are prescribing the drugs as a "chemical cosh" to subdue challenging patients, despite safety warnings issued four years ago....
